What is Consultmed?
Established in 2019, Consultmed operates at the intersection of healthcare delivery and enterprise software development. Headquartered in Australia, the company specializes in streamlining clinical workflows by assembling multidisciplinary teams of clinicians, software engineers, and designers. Their platform serves as a critical bridge in the healthcare ecosystem, facilitating more efficient communication and patient management processes. By focusing on the integration of specialized medical knowledge with scalable digital infrastructure, Consultmed addresses systemic inefficiencies that have long plagued traditional healthcare delivery models. Their market position is defined by a commitment to evidence-based design and a deep understanding of the complex regulatory and operational requirements inherent in the Australian medical landscape.
How much funding has Consultmed raised?
Consultmed has raised a total of $1.2M across 1 funding round:
Other Financing Round
$1.2M
Other Financing Round (2022): $1.2M with participation from Investible
Key Investors in Consultmed
Investible
Investible is an early-stage venture capital firm focused on supporting visionary tech entrepreneurs across the Asia-Pacific region, providing both capital and strategic guidance to startups from Pre-Seed to Series A.
What's next for Consultmed?
Looking ahead, the strategic deployment of the $1.2M will likely focus on product iteration and the expansion of the company's core service offerings. As Consultmed transitions into a more mature phase of its lifecycle, the focus will shift toward deepening its market penetration and potentially exploring cross-border opportunities within the Asia-Pacific region. The backing from key institutional partners provides not only the necessary liquidity for operational scaling but also access to a broader network of industry expertise. Future growth will be contingent upon the company's ability to maintain its high standards of clinical efficacy while navigating the rapid evolution of digital health regulations. Investors will be monitoring the firm's ability to convert this capital into sustainable, long-term enterprise value as it continues to disrupt traditional healthcare paradigms.
See full Consultmed company page
